Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3048

Actual shortage: 226 (7%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2799 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE 8MG TABLET Resolved 2021-09-21 2021-10-25 145937
APO-HYDROMORPHONE 8MG TABLET Resolved 2021-11-12 2021-12-20 149167
APO-HYDROMORPHONE 2MG TABLET Resolved 2022-02-04 2022-02-22 154175
APO-HYDROMORPHONE 8MG TABLET Resolved 2023-06-09 2023-10-15 194587
APO-HYDROMORPHONE 2MG TABLET Resolved 2023-09-01 2023-09-28 203548
APO-HYDROMORPHONE 4MG TABLET Resolved 2023-09-07 2023-11-06 203852
APO-HYDROMORPHONE 1MG TABLET Resolved 2023-10-27 2023-12-15 208397
APO-HYDROMORPHONE 2MG TABLET Resolved 2023-12-01 2024-01-12 212383
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-03 2020-04-04 71124
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-03 2020-04-04 71127
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Resolved 2019-01-30 2020-04-04 74019
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77849
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77852
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77855
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-05 2020-04-04 77858
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Resolved 2019-03-20 2020-04-04 79039
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-11-13 2020-04-04 98562
APO-HYDROXYQUINE 200MG TABLET Resolved 2017-09-04 2017-11-20 20875
APO-HYDROXYQUINE 200MG TABLET Resolved 2020-03-20 2020-04-24 109087
APO-HYDROXYQUINE 200MG TABLET Actual shortage 2024-05-24 2024-05-24 228780

Showing 1241 to 1260 of 3048

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971

Showing 161 to 180 of 356